U.S. Tumor Ablation Market Size, Share & Trends Analysis Report By Technology, By Treatment (Surgical, Laparoscopic), By Application (Liver Cancer, Kidney Cancer), And Segment Forecasts, 2024 - 2030

Table of Contents

Chapter 1. Methodology and Scope
                   1.1. Market Segmentation & Scope
                       1.1.1. Technology
                       1.1.2. Treatment
                       1.1.3. Application
                       1.1.4. Estimates and forecast timeline
                   1.2. Research Methodology
                   1.3. Information Procurement
                       1.3.1. Purchased database
                       1.3.2. GVR’s internal database
                       1.3.3. Secondary sources
                       1.3.4. Primary research
                       1.3.5. Details of primary research
                   1.4. Information or Data Analysis
                       1.4.1. Data analysis models
                   1.5. Market Formulation & Validation
                   1.6. Model Details
                       1.6.1. Commodity flow analysis (Model 1)
                       1.6.2. Approach 1: Commodity flow approach
                       1.6.3. Volume price analysis (Model 2)
                       1.6.4. Approach 2: Volume price analysis
                   1.7. List of Secondary Sources
                   1.8. List of Primary Sources
                   1.9. Objectives
Chapter 2. Executive Summary
                   2.1. Market Outlook
                   2.2. Segment Outlook
                       2.2.1. Technology outlook
                       2.2.2. Treatment outlook
                       2.2.3. Application outlook
                   2.3. Competitive Insights
Chapter 3. U.S. Tumor Ablation Market Variables, Trends & Scope
                   3.1. Market Lineage Outlook
                       3.1.1. Parent market outlook
                       3.1.2. Related/ancillary market outlook
                   3.2. Market Dynamics
                       3.2.1. Market driver analysis
                           3.2.1.1. Rising incidence of cancer
                           3.2.1.2. Technological advancements in ablation devices
                           3.2.1.3. Increasing per capita income
                           3.2.1.4. Growing demand of minimally invasive surgeries.
                       3.2.2. Market restraint analysis
                           3.2.2.1. Stringent regulations & approvals
                           3.2.2.2. Presence of alternative treatment options
                   3.3. Tumor Ablation Market Analysis Tools
                       3.3.1. Industry Analysis - Porter’s
                           3.3.1.1. Supplier power
                           3.3.1.2. Buyer power
                           3.3.1.3. Substitution threat
                           3.3.1.4. Threat of new entrant
                           3.3.1.5. Competitive rivalry
                       3.3.2. PESTEL Analysis
                           3.3.2.1. Political landscape
                           3.3.2.2. Technological landscape
                           3.3.2.3. Economic landscape
Chapter 4. U.S. Tumor Ablation Market: Technology Estimates & Trend Analysis
                   4.1. Definitions and Scope
                       4.1.1. Radiofrequency ablation
                       4.1.2. Microwave ablation
                       4.1.3. Cryoablation
                       4.1.4. Irreversible electroporation ablation
                       4.1.5. HIFU
                       4.1.6. Other ablation technologies
                   4.2. Technology Market Share, 2023 & 2030
                   4.3. Segment Dashboard
                   4.4. U.S. Tumor Ablation Market by Technology Outlook
                   4.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
                       4.5.1. Radiofrequency ablation
                           4.5.1.1. Market estimates and forecast 2018 to 2030 (USD Million)
                       4.5.2. Microwave Ablation
                           4.5.2.1. Market estimates and forecast 2018 to 2030 (USD Million)
                       4.5.3. Cryoablation
                           4.5.3.1. Market estimates and forecast 2018 to 2030 (USD Million)
                       4.5.4. Irreversible electroporation ablation
                           4.5.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
                       4.5.5. HIFU
                           4.5.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
                       4.5.6. Other ablation technologies
                           4.5.6.1. Market estimates and forecast 2018 to 2030 (USD Million)
Chapter 5. U.S. Tumor Ablation Market: Treatment Estimates & Trend Analysis
                   5.1. Definitions and Scope
                       5.1.1. Surgical ablation
                       5.1.2. Laparoscopic ablation
                       5.1.3. Percutaneous ablation
                   5.2. Treatment Market Share, 2023 & 2030
                   5.3. Segment Dashboard
                   5.4. U.S. Tumor Ablation Market by Treatment Outlook
                   5.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
                       5.5.1. Surgical ablation
                           5.5.1.1. Market estimates and forecast 2018 to 2030 (USD Million)
                       5.5.2. Laparoscopic ablation
                           5.5.2.1. Market estimates and forecast 2018 to 2030 (USD Million)
                       5.5.3. Percutaneous ablation
                           5.5.3.1. Market estimates and forecast 2018 to 2030 (USD Million)
Chapter 6. U.S. Tumor Ablation Market: Application Estimates & Trend Analysis
                   6.1. Definitions and Scope
                       6.1.1. Kidney cancer
                       6.1.2. Liver cancer
                       6.1.3. Breast cancer
                       6.1.4. Lung cancer
                       6.1.5. Prostate cancer
                       6.1.6. Other cancer
                   6.2. Application Market Share, 2023 & 2030
                   6.3. Segment Dashboard
                   6.4. U.S. Tumor Ablation Market by Application Outlook
                   6.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
                       6.5.1. Kidney cancer
                           6.5.1.1. Market estimates and forecast 2018 to 2030 (USD million)
                       6.5.2. Liver cancer
                           6.5.2.1. Market estimates and forecast 2018 to 2030 (USD Million)
                       6.5.3. Breast cancer
                           6.5.3.1. Market estimates and forecast 2018 to 2030 (USD Million)
                       6.5.4. Lung cancer
                           6.5.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
                       6.5.5. Prostate cancer
                           6.5.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
                       6.5.6. Other cancer
                           6.5.6.1. Market estimates and forecast 2018 to 2030 (USD Million)
Chapter 7. Competitive Landscape
                   7.1. Recent Developments & Impact Analysis, By Key Market Participants
                   7.2. Company/Competition Categorization
                       7.2.1. Innovators
                   7.3. Vendor Landscape
                       7.3.1. List of key distributors and channel partners
                       7.3.2. Key customers
                       7.3.3. Key company market share analysis, 2023
                       7.3.4. Medtronic
                           7.3.4.1. Company overview
                           7.3.4.2. Financial performance
                           7.3.4.3. Product benchmarking
                           7.3.4.4. Strategic initiatives
                       7.3.5. Boston Scientific Corporation
                           7.3.5.1. Company overview
                           7.3.5.2. Financial performance
                           7.3.5.3. Product benchmarking
                           7.3.5.4. Strategic initiatives
                       7.3.6. Johnson & Johnson Service Inc. (Ethicon, Inc.)
                           7.3.6.1. Company overview
                           7.3.6.2. Financial performance
                           7.3.6.3. Product benchmarking
                           7.3.6.4. Strategic initiatives
                       7.3.7. AngioDynamics
                           7.3.7.1. Company overview
                           7.3.7.2. Financial performance
                           7.3.7.3. Product benchmarking
                           7.3.7.4. Strategic initiatives
                       7.3.8. Bioventus Inc. (Misonix Inc.)
                           7.3.8.1. Company overview
                           7.3.8.2. Financial performance
                           7.3.8.3. Product benchmarking
                           7.3.8.4. Strategic initiatives
                       7.3.9. EDAP TMS
                           7.3.9.1. Company overview
                           7.3.9.2. Financial performance
                           7.3.9.3. Product benchmarking
                           7.3.9.4. Strategic initiatives
                       7.3.10. Chongqing Haifu Medical Technology Co., Ltd
                           7.3.10.1. Company overview
                           7.3.10.2. Financial performance
                           7.3.10.3. Product benchmarking
                           7.3.10.4. Strategic initiatives
                       7.3.11. Mermaid Medical
                           7.3.11.1. Company overview
                           7.3.11.2. Financial performance
                           7.3.11.3. Product benchmarking
                           7.3.11.4. Strategic initiatives
                       7.3.12. HealthTronics, Inc.
                           7.3.12.1. Company overview
                           7.3.12.2. Financial performance
                           7.3.12.3. Product benchmarking
                           7.3.12.4. Strategic initiatives
                       7.3.13. H.S. Hospital Service S.p.A.
                           7.3.13.1. Company overview
                           7.3.13.2. Financial performance
                           7.3.13.3. Product benchmarking
                           7.3.13.4. Strategic initiatives

List of Tables

Table 1 List of Abbreviations
Table 2 U.S. tumor ablation market, by technology, 2018 - 2030 (USD Million)
Table 3 U.S. tumor ablation market, by treatment, 2018 - 2030 (USD Million)
Table 4 U.S. tumor ablation market, by application, 2018 - 2030 (USD Million)

List of Tables

Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Tumor ablation market: market outlook
Fig. 9 Tumor ablation competitive insights
Fig. 10 Parent market outlook
Fig. 11 Related/ancillary market outlook
Fig. 12 Penetration and growth prospect mapping
Fig. 13 Industry value chain analysis
Fig. 14 Tumor ablation market driver impact
Fig. 15 Tumor ablation market restraint impact
Fig. 16 Tumor ablation market strategic initiatives analysis
Fig. 17 Tumor ablation market: Technology movement analysis
Fig. 18 Tumor ablation market: Technology outlook and key takeaways
Fig. 19 Radiofrequency ablation market estimates and forecast, 2018 - 2030
Fig. 20 Microwave ablation estimates and forecast, 2018 - 2030
Fig. 21 Cryoablation market estimates and forecast, 2018 - 2030
Fig. 22 Irreversible electroporation ablation estimates and forecast, 2018 - 2030
Fig. 23 HIFU market estimates and forecast, 2018 - 2030
Fig. 24 Others estimates and forecast, 2018 - 2030
Fig. 25 Tumor ablation Market: Treatment Movement Analysis
Fig. 26 Tumor ablation market: Treatment outlook and key takeaways
Fig. 27 Surgical ablation market estimates and forecast, 2018 - 2030
Fig. 28 Percutaneous ablation market estimates and forecast,2018 - 2030
Fig. 29 Laparoscopic ablation market estimates and forecast,2018 - 2030
Fig. 30 Tumor ablation market: application movement analysis
Fig. 31 Tumor ablation market: application outlook and key takeaways
Fig. 32 Kidney cancer market estimates and forecast, 2018 - 2030
Fig. 33 Liver cancer market estimates and forecast,2018 - 2030
Fig. 34 Breast cancer market estimates and forecast, 2018 - 2030
Fig. 35 Lung cancer market estimates and forecast,2018 - 2030
Fig. 36 Prostate cancer market estimates and forecast, 2018 - 2030
Fig. 37 Other market estimates and forecast,2018 - 2030
Fig. 38 Market share of key market players- Tumor ablation market